A spotlight on cancer researchers in Spain: new paradigms and disruptive ideas
Santiago Ramón y Cajal(Instituto de Salud Carlos III), Alberto J. Schuhmacher(Spanish National Cancer Research Centre), Héctor Peinado(Centro Nacional de Biotecnología), Vı́ctor Quesada(Universidad de Oviedo), Patricia Sancho(Queen Mary University of London), J. Jimeno(NewGen Therapeutics (United States)), Manuel Valiente(Instituto de Filosofía), Ignacio Varela(Wellcome Sanger Institute), Laura Soucek(Institució Catalana de Recerca i Estudis Avançats), María Abad(Universidad San Pablo CEU), A. Antón(Hospital Universitario Miguel Servet), Alejo Efeyan(Spanish National Cancer Research Centre), Julián Pardo(Universidad de Zaragoza)
Cited by 0
Related Papers
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k